Package Leaflet: Information for the User
Aracenac 100 mg Film-Coated Tablets EFG
Aceclofenac
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What is Aracenac and what it is used for
2. What you need to know before you start taking Aracenac
3. How to take Aracenac
4. Possible side effects
5. Storage of Aracenac
6. Contents of the pack and additional information
Aracenac is an effective medication for reducing pain and inflammation.
This medication is used in adults for the treatment of inflammatory and painful processes such as lower back pain (lumbalgia), toothache (odontalgia) and joint pain (periartritis escapulohumeral and extrarticular rheumatism). It is also used in the chronic treatment of pain and inflammation associated with chronic joint processes: osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
It is essential to use the smallest effective dose that relieves or controls pain and not to take this medication for longer than necessary to control your symptoms.
Do not take Aracenac:
-If you have established heart disease and/or cerebrovascular disease, for example, if you have had a heart attack, stroke, mini-stroke (TIA), or blockages in the blood vessels of the heart or brain, or a surgery to remove some obstruction or coronary bypass.
-If you have or have had problems with blood circulation (peripheral arterial disease).
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication
This risk is higher when using high doses and prolonged treatments, in patients with a history of peptic ulcer and in elderly patients. In these cases, your doctor will consider the possibility of associating a stomach protector medication.
Elderly patients suffer a higher incidence of adverse effects, specifically bleeding and perforations of the gastrointestinal tract (in some cases fatal),
It is essential to use the smallest effective dose that relieves or controls pain and not to take this medication for longer than necessary to control your symptoms.
Medications like aceclofenac may be associated with a moderate increase in the risk of suffering heart attacks ("myocardial infarctions") or strokes. This risk is more likely to occur when using high doses and prolonged treatments. Do not exceed the recommended dose or treatment duration.
Similarly, this type of medication may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
The adverse effects can be minimized by using the lowest effective dose for the shortest time possible. Do not exceed the recommended dose or treatment duration.
Other medications and Aracenac
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Certain medications may interact with aceclofenac. In these cases, it may be necessary to change the dose or discontinue treatment with one of the medications.
This is especially important when taking lithium, digoxin, diuretics, antihypertensives, anticoagulants, antiplatelet agents, hypoglycemic agents, methotrexate, corticosteroids, acetylsalicylic acid, or other nonsteroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors (SSRIs), cyclosporines, tacrolimus, or zidovudine.
Aracenac with food and beverages
This medication can be taken with or without food.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Due to the administration of medications like aceclofenac being associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer the same during the first and second trimesters of pregnancy unless strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of this medication is contraindicated.
For fertile women, it should be noted that medications like aceclofenac have been associated with a decrease in the ability to conceive.
This medication should not be taken if breastfeeding.
Driving and operating machinery:
If you experience dizziness, fainting, vertigo, or other central nervous system alterations while taking this medication, do not drive or use any hazardous tools or machinery.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will prescribe the most effective dose at the lowest possible level for the shortest time possible to reduce side effects.
This medication is administered orally. The tablets should be swallowed whole with a sufficient amount of water.
The recommended dose in adults is 200 mg per day, that is, one tablet in the morning and another at night (1 tablet every 12 hours), before or after meals (see "Taking Aracenac with food and drinks" section).
The duration of treatment will be established by your doctor. Do not stop treatment before the indicated time, even if you feel well.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
Use in children and adolescents:
Not recommended.
Use in elderly patients:
Your doctor will indicate the dose to take and should perform regular checks.
Use in patients with renal insufficiency or heart failure:
Your doctor will indicate the dose to take and should perform regular checks.
Use in patients with liver insufficiency:
The dose should be reduced to 1 tablet per day.
Long-term treatment:
If you take aceclofenac for a long period of time, your doctor should perform quarterly checks, for example, of the kidneys, liver, and blood tests.
If you take more Aracenac than you should:
In case of overdose or accidental ingestion, consult your doctor, pharmacist, go to the nearest hospital, or call the Toxicological Information Service (phone 91 562 04 20) indicating the medication and the amount ingested.
If you forgot to take Aracenac:
Take your dose as soon as possible. If there is little time left to take the next dose, wait until then to take your tablet.
Do not take a double dose to compensate for the missed doses. Take the next dose according to the usual schedule.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicinemay cause side effects, although not everyone will experience them.
The side effects that may occur are described below according to their frequency of presentation.
Frequent(may affect up to 1 in 10 patients):
Infrequent(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1000 patients):
Very rare(may affect up to 1 in 10,000 patients):
Exceptionally, severe skin infections have been observed during chickenpox.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 30 °C.
Do not usethis medicationafter the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Aracenac
- The active principle of this medication is aceclofenac. Each tablet contains 100 mg of aceclofenac.
- The other components (excipients) are: Tablet core: microcrystalline cellulose, sodium croscarmellose, povidone, and glyceryl palmitostearate. Coating: hydroxypropylmethylcellulose, microcrystalline cellulose, polyoxethylene 40 stearate, and titanium dioxide (E-171).
Coated tablets, round, white, biconvex.
It is presented in containers of 20 or 40 tablets.
Only some container sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
ARAFARMA GROUP, S.A.
C/ Fray Gabriel de San Antonio 6-10
19180 Marchamalo (Guadalajara). Spain.
Tel. 949 22 56 22
Fax: 949 22 82 25
e-mail: [email protected]
Date of the last revision of this prospectus: September 2023
The detailed and updated information of this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.